Copyright ©2008 NPR. For personal, noncommercial use only. See Terms of Use. For other uses, prior permission required.

STEVE INSKEEP, host:

Families of patients killed by the tainted blood thinner Heparin testified before Congress yesterday. An FDA official said the agency needs more resources to improve drug manufacturing inspections, as NPR's Debbie Eliot reports.

DEBBIE ELIOT: Families urged members of the House Energy and Commerce Subcommittee to do more to protect the nation's drug supply. Joanna Marie Staples lost her husband, Dennis, after he received contaminated Heparin during a dialysis treatment in Toledo.

Ms. JOANNA MARIE STAPLES: In this land of freedom and opportunity we've come to expect to be protected and safe. It's overwhelming to discover that there are circumstances beyond our control from which we are not sheltered. We have a false empty sense of security and we are neither safe from harm nor catastrophe.

ELIOT: The Food and Drug Administration has linked at least 81 deaths and hundreds of severe reactions to the blood thinner manufactured by Baxter International from tainted ingredients imported from China. Baxter chairman Robert Parkinson testified the contamination was intentional.

Mr. ROBERT PARKINSON (Baxter International): We're alarmed that one of our products was used in what appears to have been a deliberate scheme to adulterate a life-saving medication, and that people have suffered as a result. We deeply regret that this has happened, and I feel a strong sense of personal responsibility for these circumstances.

ELIOT: Parkinson said the complexity of the global drug supply chain calls for new drug safety standards.

Debbie Eliot, NPR News, the Capitol.

Copyright © 2008 NPR. All rights reserved. No quotes from the materials contained herein may be used in any media without attribution to NPR. This transcript is provided for personal, noncommercial use only, pursuant to our Terms of Use. Any other use requires NPR's prior permission. Visit our permissions page for further information.

NPR transcripts are created on a rush deadline by a contractor for NPR, and accuracy and availability may vary. This text may not be in its final form and may be updated or revised in the future. Please be aware that the authoritative record of NPR's programming is the audio.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.